First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Plans Quarterly Dividend of $0.09

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) announced a quarterly dividend on Wednesday, June 24th, NASDAQ Dividends reports. Shareholders of record on Thursday, June 25th will be given a dividend of 0.092 per share on Tuesday, June 30th. This represents a c) annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Thursday, June 25th. This is a 60.6% increase from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.06.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

FTXH stock traded up $0.34 during trading hours on Thursday, reaching $37.12. The stock had a trading volume of 2,522 shares, compared to its average volume of 7,698. The stock has a market capitalization of $33.41 million, a PE ratio of 14.51 and a beta of 0.47. The stock has a 50-day simple moving average of $34.71 and a 200 day simple moving average of $34.18. First Trust Nasdaq Pharmaceuticals ETF has a fifty-two week low of $25.58 and a fifty-two week high of $37.60.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.